Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Hepatology International|August 12, 2009
Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5AMasaru Moriyama, Naoya Kato, Motoyuki Otsuka, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis CNarayan Dharel, Naoya Kato, Ryosuke Muroyama, et al.Gastroenterology|January 6, 2005
Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathwaysRun-Xuan Shao, Motoyuki Otsuka, Naoya Kato, et al.Plos One|February 24, 2012
ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replicationLeiliang Zhang, Zhi Hong, Wenyu Lin, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2008
Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patientsRadsamee Sermasathanasawadi, Naoya Kato, Ryosuke Muroyama, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2009
Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replicationChang-Zheng Li, Naoya Kato, Jin-Hai Chang, et al.Hepatology (Baltimore, Md.)|July 9, 2004
Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activationMotoyuki Otsuka, Naoya Kato, Run-Xuan Shao, et al.World Journal of Gastroenterology|April 1, 2005
Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patientsRun-Xuan Shao, Yujin Hoshida, Motoyuki Otsuka, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2009
Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatmentJin-Hai Chang, Naoya Kato, Ryosuke Muroyama, et al.Journal of Virology|April 9, 2010
Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent mannerRun-Xuan Shao, Leiliang Zhang, Lee F Peng, et al.Pageof 3